Literature DB >> 25666674

Unfolding the mutational landscape of human melanoma.

Diwakar Davar1, Yan Lin2, John M Kirkwood3.   

Abstract

Over the preceding two decades, sophisticated sequencing techniques have been used to characterize the genetic drivers of adult melanoma. However, our understanding of pediatric melanomas is still rudimentary. In this report, we comment on a thorough multi-platform analysis of common pediatric melanoma subsets, including pediatric conventional melanoma (CM), congenital nevus-derived melanoma (CNM), and Spitzoid melanoma (SM), contributed by Lu et al.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25666674      PMCID: PMC4466551          DOI: 10.1038/jid.2014.467

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  17 in total

1.  Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model.

Authors:  Vernon K Sondak; Jeremy M G Taylor; Michael S Sabel; Yue Wang; Lori Lowe; Amelia C Grover; Alfred E Chang; Alan M Yahanda; James Moon; Timothy M Johnson
Journal:  Ann Surg Oncol       Date:  2004-03       Impact factor: 5.344

2.  Distinct sets of genetic alterations in melanoma.

Authors:  John A Curtin; Jane Fridlyand; Toshiro Kageshita; Hetal N Patel; Klaus J Busam; Heinz Kutzner; Kwang-Hyun Cho; Setsuya Aiba; Eva-Bettina Bröcker; Philip E LeBoit; Dan Pinkel; Boris C Bastian
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

3.  Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization.

Authors:  B C Bastian; P E LeBoit; H Hamm; E B Bröcker; D Pinkel
Journal:  Cancer Res       Date:  1998-05-15       Impact factor: 12.701

4.  Somatic activation of KIT in distinct subtypes of melanoma.

Authors:  John A Curtin; Klaus Busam; Daniel Pinkel; Boris C Bastian
Journal:  J Clin Oncol       Date:  2006-08-14       Impact factor: 44.544

5.  Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.

Authors:  P Guldberg; P thor Straten; A Birck; V Ahrenkiel; A F Kirkin; J Zeuthen
Journal:  Cancer Res       Date:  1997-09-01       Impact factor: 12.701

Review 6.  Mutations induced by ultraviolet light.

Authors:  Gerd P Pfeifer; Young-Hyun You; Ahmad Besaratinia
Journal:  Mutat Res       Date:  2005-01-20       Impact factor: 2.433

7.  Loss of heterozygosity for 10q22-10qter in malignant melanoma progression.

Authors:  R A Herbst; J Weiss; A Ehnis; W K Cavenee; K C Arden
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

8.  Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus.

Authors:  A Kamb; D Shattuck-Eidens; R Eeles; Q Liu; N A Gruis; W Ding; C Hussey; T Tran; Y Miki; J Weaver-Feldhaus
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

9.  Patterns of somatic mutation in human cancer genomes.

Authors:  Christopher Greenman; Philip Stephens; Raffaella Smith; Gillian L Dalgliesh; Christopher Hunter; Graham Bignell; Helen Davies; Jon Teague; Adam Butler; Claire Stevens; Sarah Edkins; Sarah O'Meara; Imre Vastrik; Esther E Schmidt; Tim Avis; Syd Barthorpe; Gurpreet Bhamra; Gemma Buck; Bhudipa Choudhury; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Kris Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jon Hinton; Andy Jenkinson; David Jones; Andy Menzies; Tatiana Mironenko; Janet Perry; Keiran Raine; Dave Richardson; Rebecca Shepherd; Alexandra Small; Calli Tofts; Jennifer Varian; Tony Webb; Sofie West; Sara Widaa; Andy Yates; Daniel P Cahill; David N Louis; Peter Goldstraw; Andrew G Nicholson; Francis Brasseur; Leendert Looijenga; Barbara L Weber; Yoke-Eng Chiew; Anna DeFazio; Mel F Greaves; Anthony R Green; Peter Campbell; Ewan Birney; Douglas F Easton; Georgia Chenevix-Trench; Min-Han Tan; Sok Kean Khoo; Bin Tean Teh; Siu Tsan Yuen; Suet Yi Leung; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962

10.  The genomic landscape of childhood and adolescent melanoma.

Authors:  Charles Lu; Jinghui Zhang; Panduka Nagahawatte; John Easton; Seungjae Lee; Zhifa Liu; Li Ding; Matthew A Wyczalkowski; Marcus Valentine; Fariba Navid; Heather Mulder; Ruth G Tatevossian; James Dalton; James Davenport; Zhirong Yin; Michael Edmonson; Michael Rusch; Gang Wu; Yongjin Li; Matthew Parker; Erin Hedlund; Sheila Shurtleff; Susana Raimondi; Vadodaria Bhavin; Yergeau Donald; Elaine R Mardis; Richard K Wilson; William E Evans; David W Ellison; Stanley Pounds; Michael Dyer; James R Downing; Alberto Pappo; Armita Bahrami
Journal:  J Invest Dermatol       Date:  2014-09-30       Impact factor: 8.551

View more
  10 in total

1.  Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.

Authors:  Alexandre Reuben; Christine N Spencer; Peter A Prieto; Vancheswaran Gopalakrishnan; Sangeetha M Reddy; John P Miller; Xizeng Mao; Mariana Petaccia De Macedo; Jiong Chen; Xingzhi Song; Hong Jiang; Pei-Ling Chen; Hannah C Beird; Haven R Garber; Whijae Roh; Khalida Wani; Eveline Chen; Cara Haymaker; Marie-Andrée Forget; Latasha D Little; Curtis Gumbs; Rebecca L Thornton; Courtney W Hudgens; Wei-Shen Chen; Jacob Austin-Breneman; Robert Szczepaniak Sloane; Luigi Nezi; Alexandria P Cogdill; Chantale Bernatchez; Jason Roszik; Patrick Hwu; Scott E Woodman; Lynda Chin; Hussein Tawbi; Michael A Davies; Jeffrey E Gershenwald; Rodabe N Amaria; Isabella C Glitza; Adi Diab; Sapna P Patel; Jianhua Hu; Jeffrey E Lee; Elizabeth A Grimm; Michael T Tetzlaff; Alexander J Lazar; Ignacio I Wistuba; Karen Clise-Dwyer; Brett W Carter; Jianhua Zhang; P Andrew Futreal; Padmanee Sharma; James P Allison; Zachary A Cooper; Jennifer A Wargo
Journal:  NPJ Genom Med       Date:  2017-04-07       Impact factor: 8.617

2.  Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer.

Authors:  Daniel Nava Rodrigues; Pasquale Rescigno; David Liu; Wei Yuan; Suzanne Carreira; Maryou B Lambros; George Seed; Joaquin Mateo; Ruth Riisnaes; Stephanie Mullane; Claire Margolis; Diana Miao; Susana Miranda; David Dolling; Matthew Clarke; Claudia Bertan; Mateus Crespo; Gunther Boysen; Ana Ferreira; Adam Sharp; Ines Figueiredo; Daniel Keliher; Saud Aldubayan; Kelly P Burke; Semini Sumanasuriya; Mariane Sousa Fontes; Diletta Bianchini; Zafeiris Zafeiriou; Larissa Sena Teixeira Mendes; Kent Mouw; Michael T Schweizer; Colin C Pritchard; Stephen Salipante; Mary-Ellen Taplin; Himisha Beltran; Mark A Rubin; Marcin Cieslik; Dan Robinson; Elizabeth Heath; Nikolaus Schultz; Joshua Armenia; Wassim Abida; Howard Scher; Christopher Lord; Alan D'Andrea; Charles L Sawyers; Arul M Chinnaiyan; Andrea Alimonti; Peter S Nelson; Charles G Drake; Eliezer M Van Allen; Johann S de Bono
Journal:  J Clin Invest       Date:  2018-09-04       Impact factor: 14.808

3.  Synthetic lethality of a cell-penetrating anti-RAD51 antibody in PTEN-deficient melanoma and glioma cells.

Authors:  Audrey Turchick; Yanfeng Liu; Weixi Zhao; Inessa Cohen; Peter M Glazer
Journal:  Oncotarget       Date:  2019-02-12

4.  PLA1A expression as a diagnostic marker of BRAF-mutant metastasis in melanoma cancer.

Authors:  Gang Yang; Shuya Liu; Mazaher Maghsoudloo; Marzieh Dehghan Shasaltaneh; Parham Jabbarzadeh Kaboli; Cuiwei Zhang; Youcai Deng; Hajar Heidari; Maliheh Entezari; ShaoZhi Fu; QingLian Wen; Saber Imani
Journal:  Sci Rep       Date:  2021-03-15       Impact factor: 4.379

Review 5.  Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer.

Authors:  Dhruv Bansal; Melissa A Reimers; Eric M Knoche; Russell K Pachynski
Journal:  Cancers (Basel)       Date:  2021-01-18       Impact factor: 6.639

6.  Unbiased High-Throughput Drug Combination Pilot Screening Identifies Synergistic Drug Combinations Effective against Patient-Derived and Drug-Resistant Melanoma Cell Lines.

Authors:  David A Close; John M Kirkwood; Ronald J Fecek; Walter J Storkus; Paul A Johnston
Journal:  SLAS Discov       Date:  2020-11-18       Impact factor: 3.341

Review 7.  Pediatric melanoma: incidence, treatment, and prognosis.

Authors:  Faiez K Saiyed; Emma C Hamilton; Mary T Austin
Journal:  Pediatric Health Med Ther       Date:  2017-04-18

Review 8.  Challenging the standard of care in advanced melanoma: focus on pembrolizumab.

Authors:  Raghad M Abdul-Karim; C Lance Cowey
Journal:  Cancer Manag Res       Date:  2017-09-25       Impact factor: 3.989

9.  Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignancies.

Authors:  Jason Cham; Li Zhang; Serena Kwek; Alan Paciorek; Tao He; Grant Fong; David Y Oh; Lawrence Fong
Journal:  J Immunother Cancer       Date:  2020-05       Impact factor: 13.751

Review 10.  Immunotherapy in Advanced Prostate Cancer: Current Knowledge and Future Directions.

Authors:  Fernando López-Campos; Pablo Gajate; Nuria Romero-Laorden; Juan Zafra-Martín; Manel Juan; Susana Hernando Polo; Antonio Conde Moreno; Felipe Couñago
Journal:  Biomedicines       Date:  2022-02-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.